Evaluation of Efficacy, Safety, and Tolerability of Imeglimin Hydrochloride SR Tablets 1000 mg in Participants with Inadequately Controlled Type 2 Diabetes Mellitus: A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Clinical Study from India

Evaluation of Efficacy, Safety, and Tolerability of Imeglimin Hydrochloride SR Tablets 1000 mg in Participants with Inadequately Controlled Type 2 Diabetes Mellitus: A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Clinical Study from India

Background: Management of type 2 diabetes mellitus (T2DM) focuses on achieving target HbA1c levels, but poor glycemic control remains prevalent among Indian patients. The approval of imeglimin and its use in India highlight its potential as an effective treatment option, but the lack of phase III cl...

Full description

Saved in:
Bibliographic Details
Main Authors: Prashant Kumthekar, Mihir Upadhyay, Vijay Kranti, Sanjiv Maheshwari, Arindam Ray, Raja Bhattacharya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Journal of Diabetology
Subjects:
glycemic response
hba1c
imeglimin hydrochloride
monotherapy
sustained release
Online Access:https://doi.org/10.4103/jod.jod_208_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.4103/jod.jod_208_24

Similar Items